Claudio Passananti

Claudio Passananti is an accomplished inventor based in Rome, Italy. He has made significant contributions to the field of medical research, particularly in the treatment of muscular dystrophy. With a total of 3 patents to his name, his work focuses on innovative methods and compositions aimed at addressing muscle diseases.

Latest Patents

Among his latest patents, Claudio has developed compositions and methods for the treatment of muscular dystrophy. One notable invention features modified human transcription factors capable of increasing utrophin expression. This invention also includes recombinant adeno-associated vectors for the delivery of these modified transcription factors, along with methods for treating muscle diseases, including Duchenne's muscular dystrophy. Another significant patent involves recombinant adeno-associated vectors designed for delivering genes to both skeletal and cardiac muscle, providing methods for treating muscle defects, particularly in cases of Duchenne's muscular dystrophy.

Career Highlights

Claudio Passananti is affiliated with the National Research Council (Consiglio Nazionale Delle Ricerche), where he continues to advance his research and innovations. His work has garnered attention for its potential impact on the treatment of debilitating muscle diseases.

Collaborations

Claudio collaborates with esteemed colleagues, including Nicoletta Corbi and Maria Grazia Di Certo, who contribute to his research endeavors and help in the development of innovative solutions for muscular dystrophy.

Conclusion

Claudio Passananti's contributions to the field of muscular dystrophy treatment highlight his dedication to innovation and research. His patents reflect a commitment to improving the lives of those affected by muscle diseases.